Zurich Cantonal Bank’s Zomedica Corp. ZOM Stock Holding History

Zurich Cantonal Bank’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-272,982	Closed	-$92K	–	2986
2022 Q1	$92K	Buy	272,982 +136,491	+100%	+$44.7K	﹤0.01%	2324
2021 Q4	$42K	Hold	136,491	–	–	﹤0.01%	2784
2021 Q3	$71K	Hold	136,491	–	–	﹤0.01%	2504
2021 Q2	$112K	Buy	+136,491	New	+$127K	﹤0.01%	2164

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Zurich Cantonal Bank's ZOM Position: Q2 2022 in Review

Zurich Cantonal Bank sold out of Zomedica Corp. (ZOM) in Q2 2022, closing a stake of 272,982 shares — an estimated $92K sold.

Zurich Cantonal Bank first reported a position in ZOM in Q2 2021 and held it in 4 quarters. The position peaked at $112K in Q2 2021. 97 funds tracked by Wall St. Rank hold ZOM as of Q2 2022.

Zurich Cantonal Bank reported no remaining Zomedica Corp. position as of Q2 2022 after selling out during the quarter.
Zurich Cantonal Bank sold 272,982 Zomedica Corp. shares in Q2 2022, an estimated $92K.
Zurich Cantonal Bank first reported a position in Zomedica Corp. in Q2 2021 and held it in 4 quarters.
Zurich Cantonal Bank's Zomedica Corp. position peaked at $112K in Q2 2021.
97 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.